Protective effect of erythropoietin against 1-methyl-4-phenylpyridinium- induced neurodegenaration in PC12 cells

被引：32
作者：
Wu Y. [1 ]
Shang Y. [2 ]
Sun S.-G. [1 ]
Liu R.-G. [3 ]
Yang W.-Q. [4 ]
机构：
[1] Department of Neurology, Union Hospital, Huazhong University of Science and Technology
[2] Department of Anesthesiology, Union Hospital, Huazhong University of Science and Technology
[3] Department of Anatomy, Tongji Medical College, Huazhong University of Science and Technology
[4] Department of Neurology, Dongfeng Hospital, Yunyang Medical College
来源：
Neuroscience Bulletin | 2007年 / 23卷 / 3期
基金：
中国国家自然科学基金;
关键词：
1-methyl-4-phenylpyridinium; Apoptosis; Erythropoietin; Oxidative stress; PC12; cells;
D O I：
10.1007/s12264-007-0023-0
中图分类号：
学科分类号：
摘要：
Objective: The neuroprotective effect of erythropoietin (EPO) against 1-methyl-4-phenylpyridinium (MPP+)-induced oxidative stress in cultured PC12 cells, as well as the underlying mechanism, were investigated. Methods: PC12 cells impaired by MPP+ were used as the cell model of Parkinson's disease. Methyl thiazolyl tetrazolium (MTT) was used to assay the viability of the PC12 cells exposed to gradient concentrations of EPO, and the terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) assay was used to analyze the apoptosis ratio of PC12 cells. The expression of Bcl-2 and Bax in PC12 cells were examined by Western blot, and the reactive oxygen species (ROS), the mitochondrial transmembrane potential and the activity of caspase-3 in each group were detected by spectrofluorometer. Results: Treatment of PC12 cells with MPP+ caused the loss of cell viability, which may be associated with the elevation in apoptotic rate, the formation of ROS and the disruption of mitochondrial transmembrane potential. It was also shown that MPP+ significantly induced the upregulation of Bax/Bcl-2 ratio and the activation of caspase-3. In contrast, EPO significantly reversed these responses and had the maximum protective effect at 1 U/mL. Conclusion: The inhibitive effect of EPO on the MPP+-induced cytotoxicity may be ascribed to its anti-oxidative property and anti-apoptotic activity, and EPO may provide a useful therapeutic strategy for treatment of neurodegenerative diseases such as Parkinson's disease.
引用
收藏
页码：156 / 164
页数：8
相关论文
共 38 条
  • [21] Blum D., Torch S., Lambeng N., Nissou M., Benabid A.L., Sadoul R., Et al., Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: Contribution to the apoptotic theory in Parkinson's disease, Prog Neurobiol, 65, pp. 135-172, (2001)
  • [22] Liu J., Narasimhan P., Song Y.S., Nishi T., Yu F., Lee Y.S., Et al., Epo protects SOD2-deficient mouse astrocytes from damage by oxidative stress, Glia, 53, pp. 360-365, (2006)
  • [23] Ozturk E., Demirbilek S., Kadir But A., Saricicek V., Gulec M., Akyol O., Et al., Antioxidant properties of propofol and erythropoietin after closed head injury in rats, Prog Neuropsychopharmacol Biol Psychiatry, 29, pp. 922-927, (2005)
  • [24] Crowder R.J., Freeman R.S., Phosphatidylinositol 3-kinase and Akt protein kinase are necessary and sufficient for the survival of nerve growth factor-dependent sympathetic neurons, J Neurosci, 18, pp. 2933-2943, (1998)
  • [25] Philpott K.L., McCarthy M.J., Klippel A., Rubin L.L., Activated phosphatidylinositol 3-kinase and Akt kinase promote survival of superior cervical neurons, J Cell Biol, 139, pp. 809-815, (1997)
  • [26] Matsuzaki H., Tamatani M., Mitsuda N., Namikawa K., Kiyama H., Miyake S., Et al., Activation of Akt kinase inhibits apoptosis and changes in Bcl-2 and Bax expression induced by nitric oxide in primary hippocampal neurons, J Neurochem, 73, pp. 2037-2046, (1999)
  • [27] Pugazhenthi S., Nesterova A., Sable C., Heidenreich K.A., Boxer L.M., Heasley L.E., Et al., Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein, J Biol Chem, 275, pp. 10761-10766, (2000)
  • [28] Cory S., Adams J.M., The Bcl2 family: Regulators of cellular life-or-death switch, Nat Rev Cancer, 9, pp. 647-656, (2002)
  • [29] Akao Y., Otsuki Y., Kataoka S., Ito Y., Tsujimoto Y., Multiple subcellular localization of bcl-2: Detection in nuclear outer membrane, endoplasmic reticulum membrane, and mitochondrial membranes, Cancer Res, 54, pp. 2468-2471, (1994)
  • [30] Kowaltowski A.J., Vercesi A.E., Fiskum G., Bcl-2 prevents mitochondrial permeability transition and cytochrome c release via maintenance of reduced pyridine nucleotides, Cell Death Differ, 7, pp. 903-910, (2000)
1234